|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics. CA Cancer J Clin.
58:71–96. 2008.
|
|
2
|
Ha YS, Kim MJ, Yoon HY, Kang HW, Kim YJ,
Yun SJ, Lee SC and Kim WJ: mRNA expression of S100A8 as a
prognostic marker for progression of non-muscle-invasive bladder
cancer. Korean J Urol. 51:15–20. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sylvester RJ, van der Meijden AP,
Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW and
Kurth K: Predicting recurrence and progression in individual
patients with stage Ta T1 bladder cancer using EORTC risk tables: a
combined analysis of 2596 patients from seven EORTC trials. Eur
Urol. 49:S466–S477. 2006. View Article : Google Scholar
|
|
4
|
Borden LS Jr, Clark PE and Hall MC:
Bladder cancer. Curr Opin Oncol. 15:227–233. 2003. View Article : Google Scholar
|
|
5
|
Kim WJ, Kim EJ, Kim SK, Kim YJ, Ha YS,
Jeong P, Kim MJ, Yun SJ, Lee KM, Moon SK, Lee SC, Cha EJ and Bae
SC: Predictive value of progression-related gene classifier in
primary non-muscle invasive bladder cancer. Mol Cancer. 9:32010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shariat SF, Zippe C, Ludecke G, et al:
Nomograms including nuclear matrix protein 22 for prediction of
disease recurrence and progression in patients with Ta, T1 or CIS
transitional cell carcinoma of the bladder. J Urol. 173:1518–1525.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hong SJ, Cho KS, Han M, Rhew HY, Kim CS,
Ryu SB, Sul CK, Chung MK, Park TC and Kim HJ: Nomograms for
prediction of disease recurrence in patients with primary Ta, T1
transitional cell carcinoma of the bladder. J Korean Med Sci.
23:428–433. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Habuchi T, Marberger M, Droller MJ,
Hemstreet GP III, Grossman HB, Schalken JA, Schmitz-Drager BJ,
Murphy WM, Bono AV, Goebell P, Getzenberg RH, Hautmann SH, Messing
E, Fradet Y and Lokeshwar VB: Prognostic markers for bladder
cancer: International Consensus Panel on bladder tumor markers.
Urology. 66:64–74. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Babjuk M, Oosterlinck W, Sylvester R,
Kaasinen E, Bohle A and Palou-Redorta J: EAU guidelines on
non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol.
54:303–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hall MC, Chang SS, Dalbagni G, Pruthi RS,
Seigne JD, Skinner EC, Wolf JS Jr and Schellhammer PF: Guideline
for the management of nonmuscle invasive bladder cancer (stages Ta,
T1, and Tis): 2007 update. J Urol. 178:2314–2330. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Greene FL: The american joint committee on
cancer: updating the strategies in cancer staging. Bull Am Coll
Surg. 87:13–15. 2002.PubMed/NCBI
|
|
12
|
Bland JM and Altman DG: Transformations,
means, and confidence intervals. BMJ. 312:10791996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim YJ, Ha YS, Kim SK, Yoon HY, Lym MS,
Kim MJ, Moon SK, Choi YH and Kim WJ: Gene signatures for the
prediction of response to Bacillus Calmette-Guerin immunotherapy in
primary pT1 bladder cancers. Clin Cancer Res. 16:2131–2137. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen HY, Yu SL, Chen CH, Chang GC, Chen
CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN,
Liu CC, Singh S, Chen WJ, Chen JJ and Yang PC: A five-gene
signature and clinical outcome in non-small-cell lung cancer. N
Engl J Med. 356:11–20. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lossos IS, Czerwinski DK, Alizadeh AA,
Wechser MA, Tibshirani R, Botstein D and Levy R: Prediction of
survival in diffuse large-B-cell lymphoma based on the expression
of six genes. N Engl J Med. 350:1828–1837. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Beer DG, Kardia SL, Huang CC, Giordano TJ,
Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, Lizyness
ML, Kuick R, Hayasaka S, Taylor JM, Iannettoni MD, Orringer MB and
Hanash S: Gene-expression profiles predict survival of patients
with lung adenocarcinoma. Nat Med. 8:816–824. 2002.PubMed/NCBI
|
|
17
|
Skrzypski M, Jassem E, Taron M, Sanchez
JJ, Mendez P, Rzyman W, Gulida G, Raz D, Jablons D, Provencio M,
Massuti B, Chaib I, Perez-Roca L, Jassem J and Rosell R: Three-gene
expression signature predicts survival in early-stage squamous cell
carcinoma of the lung. Clin Cancer Res. 14:4794–4799. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Paik S, Shak S, Tang G, Kim C, Baker J,
Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher
ER, Wickerham DL, Bryant J and Wolmark N: A multigene assay to
predict recurrence of tamoxifen-treated, node-negative breast
cancer. N Engl J Med. 351:2817–2826. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bol MG, Baak JP, Buhr-Wildhagen S, Kruse
AJ, Kjellevold KH, Janssen EA, Mestad O and Ogreid P:
Reproducibility and prognostic variability of grade and lamina
propria invasion in stages Ta, T1 urothelial carcinoma of the
bladder. J Urol. 169:1291–1294. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Murphy WM, Takezawa K and Maruniak NA:
Interobserver discrepancy using the 1998 World Health
Organization/International Society of Urologic Pathology
classification of urothelial neoplasms: practical choices for
patient care. J Urol. 168:968–972. 2002. View Article : Google Scholar
|
|
21
|
Wu Q and Maniatis T: Large exons encoding
multiple ectodomains are a characteristic feature of protocadherin
genes. Proc Natl Acad Sci USA. 97:3124–3129. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Erkan M, Weis N, Pan Z, Schwager C,
Samkharadze T, Jiang X, Wirkner U, Giese NA, Ansorge W, Debus J,
Huber PE, Friess H, Abdollahi A and Kleeff J: Organ-, inflammation-
and cancer specific transcriptional fingerprints of pancreatic and
hepatic stellate cells. Mol Cancer. 9:882010. View Article : Google Scholar
|
|
23
|
Katoh M: WNT/PCP signaling pathway and
human cancer (Review). Oncol Rep. 14:1583–1588. 2005.PubMed/NCBI
|
|
24
|
Hirokawa N: Kinesin and dynein superfamily
proteins and the mechanism of organelle transport. Science.
279:519–526. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aizawa H, Sekine Y, Takemura R, Zhang Z,
Nangaku M and Hirokawa N: Kinesin family in murine central nervous
system. J Cell Biol. 119:1287–1296. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cui H, Dong M, Sadhu DN and Rosenberg DW:
Suppression of kinesin expression disrupts adenomatous polyposis
coli (APC) localization and affects beta-catenin turnover in young
adult mouse colon (YAMC) epithelial cells. Exp Cell Res. 280:12–23.
2002. View Article : Google Scholar
|
|
27
|
Ostrow KL, Park HL, Hoque MO, Kim MS, Liu
J, Argani P, Westra W, Van Criekinge W and Sidransky D:
Pharmacologic unmasking of epigenetically silenced genes in breast
cancer. Clin Cancer Res. 15:1184–1191. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Uchiyama CM, Zhu J, Carroll RS, Leon SP
and Black PM: Differential display of messenger ribonucleic acid: a
useful technique for analyzing differential gene expression in
human brain tumors. Neurosurgery. 37(Suppl): S464–S470. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Stearns ME and Wang M: Regulation of
kinesin expression and type IV collagenase secretion in invasive
human prostate PC-3 tumor sublines. Cancer Res. 51:5866–5875.
1991.PubMed/NCBI
|
|
30
|
Ostrow KL, Hoque MO, Loyo M, Brait M,
Greenberg A, Siegfried JM, Grandis JR, Gaither Davis A, Bigbee WL,
Rom W and Sidransky D: Molecular analysis of plasma DNA for the
early detection of lung cancer by quantitative methylation-specific
PCR. Clin Cancer Res. 16:3463–3472. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tuckwell D: Evolution of von Willebrand
factor A (VWA) domains. Biochem Soc Trans. 27:835–840.
1999.PubMed/NCBI
|
|
32
|
Robertson NG, Skvorak AB, Yin Y,
Weremowicz S, Johnson KR, Kovatch KA, Battey JF, Bieber FR and
Morton CC: Mapping and characterization of a novel cochlear gene in
human and in mouse: a positional candidate gene for a deafness
disorder, DFNA9. Genomics. 46:345–354. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rodriguez CI, Cheng JG, Liu L and Stewart
CL: Cochlin, a secreted von Willebrand factor type a
domain-containing factor, is regulated by leukemia inhibitory
factor in the uterus at the time of embryo implantation.
Endocrinology. 145:1410–1418. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Botteman MF, Pashos CL, Redaelli A, Laskin
B and Hauser R: The health economics of bladder cancer: a
comprehensive review of the published literature.
Pharmacoeconomics. 21:1315–1330. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Divrik RT, Yildirim U, Zorlu F and Ozen H:
The effect of repeat transurethral resection on recurrence and
progression rates in patients with T1 tumors of the bladder who
received intravesical mitomycin: a prospective, randomized clinical
trial. J Urol. 175:1641–1644. 2006. View Article : Google Scholar
|
|
36
|
Thalmann GN, Markwalder R, Shahin O,
Burkhard FC, Hochreiter WW and Studer UE: Primary T1G3 bladder
cancer: organ preserving approach or immediate cystectomy? J Urol.
172:70–75. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ramani VA, Bromage SJ and Clarke NW: A
contemporary standard for morbidity and outcome after radical
cystectomy. BJU Int. 104:628–632. 2009. View Article : Google Scholar : PubMed/NCBI
|
